Dilafor AB is a Swedish drug development company focusing on the development of tafoxiparin for obstetric indications.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Solna
State: Stockholms Lan
Zip:
Country: Sweden
Dilafor AB is a Swedish drug development company focusing on the development of tafoxiparin for obstetric indications. The company’s primary goal is to decrease the incidence of slow progress of labor both after induction of labor and after spontaneous onset of labor.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2016 | Venture Round | $0 |
Ostersjöstiftelsen Praktikerinvest Rosetta Capital Ostersjöstiftelsen Praktikerinvest Rosetta Capital |
9/2016 | Venture Round | 3 | $5.9M |
Ostersjöstiftelsen Praktikerinvest Rosetta Capital Ostersjöstiftelsen Praktikerinvest Rosetta Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|